Müller-Vahl KR - Search Results

1

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process.

Bhaskar A, Bell A, Boivin M, Briques W, Brown M, Clarke H, Cyr C, Eisenberg E, de Oliveira Silva RF, Frohlich E, Georgius P, Hogg M, Horsted TI, MacCallum CA, Müller-Vahl KR, O'Connell C, Sealey R, Seibolt M, Sihota A, Smith BK, Sulak D, Vigano A, Moulin DE. Bhaskar A, et al. J Cannabis Res. 2021 Jul 2;3(1):22. doi: 10.1186/s42238-021-00073-1. J Cannabis Res. 2021. PMID: 34215346 Free PMC article.

2

Vaporized Cannabis Is Effective and Well-Tolerated in an Adolescent with Tourette Syndrome.

Szejko N, Jakubovski E, Fremer C, Müller-Vahl KR. Szejko N, et al. Med Cannabis Cannabinoids. 2019 Jan 25;2(1):60-63. doi: 10.1159/000496355. eCollection 2019 Sep. Med Cannabis Cannabinoids. 2019. PMID: 34676335 Free PMC article.

3

Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey.

Milosev LM, Psathakis N, Szejko N, Jakubovski E, Müller-Vahl KR. Milosev LM, et al. Cannabis Cannabinoid Res. 2019 Dec 9;4(4):265-274. doi: 10.1089/can.2018.0050. eCollection 2019. Cannabis Cannabinoid Res. 2019. PMID: 31872061 Free PMC article.

4

Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids.

Grotenhermen F, Müller-Vahl KR. Grotenhermen F, et al. Cannabis Cannabinoid Res. 2021 Apr 15;6(2):82-87. doi: 10.1089/can.2020.0044. eCollection 2021 Apr. Cannabis Cannabinoid Res. 2021. PMID: 33912675 Free PMC article.

5

Case in Context: Tourette Syndrome.

Müller-Vahl K. Müller-Vahl K. Cannabis Cannabinoid Res. 2021 Apr;6(2):88-91. doi: 10.1089/can.2021.0005. Epub 2021 Mar 12. Cannabis Cannabinoid Res. 2021. PMID: 33989053 Free PMC article. No abstract available.

6

Cannabis Improves Stuttering: Case Report and Interview with the Patient.

Szejko N, Fremer C, Baacke F, Ptok M, Müller-Vahl KR. Szejko N, et al. Cannabis Cannabinoid Res. 2021 Oct;6(5):372-380. doi: 10.1089/can.2021.0060. Epub 2021 Jul 26. Cannabis Cannabinoid Res. 2021. PMID: 34314602 Free PMC article.

7

The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial.

Müller-Vahl KR, Pisarenko A, Ringlstetter R, Cimpianu CL, Fremer C, Weidinger E, Jenz EB, Musil R, Brunnauer A, Großhennig A. Müller-Vahl KR, et al. Cannabis Cannabinoid Res. 2024 Jan 23. doi: 10.1089/can.2023.0114. Online ahead of print. Cannabis Cannabinoid Res. 2024. PMID: 38265476

8

Cannabis Improves Obsessive-Compulsive Disorder-Case Report and Review of the Literature.

Szejko N, Fremer C, Müller-Vahl KR. Szejko N, et al. Front Psychiatry. 2020 Jul 21;11:681. doi: 10.3389/fpsyt.2020.00681. eCollection 2020. Front Psychiatry. 2020. PMID: 32848902 Free PMC article.

9

Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial.

Müller-Vahl KR, Jakubovski E, Fremer C, Lenz-Ziegenbein M, Großhennig A, Klages C, Koch A, Haas M, Pisarenko A. Müller-Vahl KR, et al. Front Neurosci. 2022 Sep 21;16:793703. doi: 10.3389/fnins.2022.793703. eCollection 2022. Front Neurosci. 2022. PMID: 36213751 Free PMC article.

10

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome.

Müller-Vahl KR, Kolbe H, Schneider U, Emrich HM. Müller-Vahl KR, et al. Acta Psychiatr Scand. 1998 Dec;98(6):502-6. doi: 10.1111/j.1600-0447.1998.tb10127.x. Acta Psychiatr Scand. 1998. PMID: 9879795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page